Macquarie Group
INFI

Macquarie Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Macquarie Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,900
Closed -$7K – 2131
2018
Q4 		$7K Buy
+5,900
New +$10.6K ﹤0.01% 2018
2018
Q1 		– Sell
-4,700
Closed -$10K – 2429
2017
Q4 		$10K Buy
+4,700
New +$9.75K ﹤0.01% 2266

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Macquarie Group's INFI Position: Q1 2019 in Review

Macquarie Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2019, closing a stake of 5,900 shares — an estimated $7K sold.

Macquarie Group first reported a position in INFI in Q4 2017 and held it in 2 quarters. The position peaked at $10K in Q4 2017. 63 funds tracked by Wall St. Rank hold INFI as of Q1 2019.

  • Macquarie Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 5,900 Infinity Pharmaceuticals, Inc. shares in Q1 2019, an estimated $7K.
  • Macquarie Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Macquarie Group's Infinity Pharmaceuticals, Inc. position peaked at $10K in Q4 2017.
  • 63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.